The benefits and risks of alemtuzumab in multiple sclerosis

被引：0
|
作者：
Ontaneda, Daniel [1 ]
Cohen, Jeffrey A. [1 ]
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2013年 / 9卷 / 03期
关键词：
alemtuzumab; efficacy; multiple sclerosis; risk; THERAPEUTIC LYMPHOCYTE DEPLETION; DISEASE;
D O I：
10.1586/ECI.13.1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：189 / 191
页数：3
相关论文
共 50 条
  • [1] ALEMTUZUMAB: BENEFITS AND CHALLENGES OF NEW THERAPY IN MULTIPLE SCLEROSIS
    Illes Zsolt
    Tobias Sejbaek
    Csepany Tuende
    [J]. IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (5-6): : 155 - 164
  • [2] Ocrelizumab in multiple sclerosis: risks and benefits
    Chaudhuri, Abhijit
    [J]. LANCET, 2012, 379 (9822): : 1196 - 1197
  • [3] Mitoxantrone: benefits and risks in multiple sclerosis patients
    Martinelli, V.
    Radaelli, M.
    Straffi, L.
    Rodegher, M.
    Comi, G.
    [J]. NEUROLOGICAL SCIENCES, 2009, 30 : 167 - 170
  • [4] Mitoxantrone: benefits and risks in multiple sclerosis patients
    V. Martinelli
    M. Radaelli
    L. Straffi
    M. Rodegher
    G. Comi
    [J]. Neurological Sciences, 2009, 30 : 167 - 170
  • [5] Mitoxantrone in the treatment of multiple sclerosis: risks and benefits
    Brochet, B
    [J]. REVUE NEUROLOGIQUE, 2006, 162 (02) : 157 - 159
  • [6] Ocrelizumab in multiple sclerosis: risks and benefits Reply
    Kappos, Ludwig
    Leppert, David
    Timmermann, Jeroen
    Glanzman, Robert
    Hauser, Stephen
    [J]. LANCET, 2012, 379 (9822): : 1197 - 1197
  • [7] Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
    Guarnera, Cristina
    Bramanti, Placido
    Mazzon, Emanuela
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 871 - 879
  • [8] Alemtuzumab for multiple sclerosis
    不详
    [J]. LANCET, 2012, 380 (9856): : 1792 - 1792
  • [9] Alemtuzumab for multiple sclerosis
    Riera, Rachel
    Porfirio, Gustavo J. M.
    Torloni, Maria R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [10] Alemtuzumab for Multiple Sclerosis
    Mark D. Willis
    Neil P. Robertson
    [J]. Current Neurology and Neuroscience Reports, 2016, 16
12345